Australia - English - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - desonide, quantity: 0.5 mg/g - lotion - excipient ingredients: light liquid paraffin; propylene glycol; sorbitan monostearate; stearyl alcohol; sodium lauryl sulfate; self-emulsifying glyceryl monostearate; cetyl alcohol; methyl hydroxybenzoate; edetate sodium; propyl hydroxybenzoate; sodium hydroxide; citric acid; purified water - desowen lotion 0.05% is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses for adults and children aged 2 years and older.

United States - English - NLM (National Library of Medicine)

galderma laboratories, l.p. - desonide (unii: j280872d1o) (desonide - unii:j280872d1o) - desonide 0.5 mg in 1 g - desowen® cream and lotion are low to medium potency corticosteroids indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. desowen® cream and lotion are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - candesartan cilexetil, quantity: 32 mg; hydrochlorothiazide, quantity: 25 mg - tablet - excipient ingredients: hyprolose; magnesium stearate; glyceryl monostearate; carmellose calcium; lactose monohydrate; maize starch; iron oxide yellow; iron oxide red - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - hydrochlorothiazide, quantity: 12.5 mg; candesartan cilexetil, quantity: 32 mg - tablet - excipient ingredients: carmellose calcium; hyprolose; maize starch; glyceryl monostearate; lactose monohydrate; magnesium stearate; iron oxide yellow - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - hydrochlorothiazide, quantity: 12.5 mg; candesartan cilexetil, quantity: 16 mg - tablet, uncoated - excipient ingredients: hyprolose; iron oxide yellow; maize starch; iron oxide red; glyceryl monostearate; carmellose calcium; lactose monohydrate; magnesium stearate - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - candesartan cilexetil, quantity: 8 mg - tablet, uncoated - excipient ingredients: magnesium stearate; carmellose calcium; hyprolose; macrogol 8000; maize starch; lactose monohydrate; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - candesartan cilexetil, quantity: 4 mg - tablet, uncoated - excipient ingredients: hyprolose; magnesium stearate; carmellose calcium; macrogol 8000; maize starch; lactose monohydrate; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - candesartan cilexetil, quantity: 32 mg - tablet, uncoated - excipient ingredients: magnesium stearate; maize starch; hyprolose; carmellose calcium; macrogol 8000; lactose monohydrate; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - candesartan cilexetil, quantity: 16 mg - tablet, uncoated - excipient ingredients: maize starch; macrogol 8000; hyprolose; magnesium stearate; carmellose calcium; lactose monohydrate; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - levonorgestrel 13.5mg - intrauterine contraceptive device - 13.5 mg - active: levonorgestrel 13.5mg excipient: dimethylsiloxane/methylvinylsiloxane cross linked elastomer dimethylsiloxane/methylvinylsiloxane cross linked elastomer t frame - contraception for up to 3 years.